Hunan Warrant Pharmaceutical Co.,Ltd (SHA:688799)
46.88
-1.53 (-3.16%)
Sep 10, 2026, 11:29 AM CST
SHA:688799 Revenue
Hunan Warrant Pharmaceutical Co.,Ltd had revenue of 336.15M CNY in the quarter ending June 30, 2026, a decrease of -10.95%. This brings the company's revenue in the last twelve months to 1.45B, up 4.55% year-over-year. In the year 2025, Hunan Warrant Pharmaceutical Co.,Ltd had annual revenue of 1.50B with 6.46% growth.
Revenue (ttm)
1.45B
Revenue Growth
+4.55%
P/S Ratio
4.46
Revenue / Employee
n/a
Employees
1,291
Market Cap
6.47B
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 1.50B | 91.28M | 6.46% |
| Dec 31, 2024 | 1.41B | -19.84M | -1.38% |
| Dec 31, 2023 | 1.43B | 140.13M | 10.84% |
| Dec 31, 2022 | 1.29B | 146.06M | 12.74% |
| Dec 31, 2021 | 1.15B | 195.97M | 20.61% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2014 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Related Stocks
| Company Name | Revenue |
|---|---|
| Northeast Pharmaceutical Group | 6.56B |
| KPC Pharmaceuticals,Inc. | 4.87B |
| Cisen Pharmaceutical | 3.40B |
| Guizhou Bailing Group Pharmaceutical | 2.56B |
| Sunflower Pharmaceutical Group | 2.51B |
| Jinghua Pharmaceutical Group | 1.48B |
| Hunan Er-Kang Pharmaceutical | 1.05B |
| Hainan Haiyao | 702.17M |